http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009513960-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-34 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 |
| filingDate | 2006-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009513960-A |
| titleOfInvention | In vitro method for diagnosing neurodegenerative diseases |
| abstract | An in vitro method for the detection of neurodegenerative diseases, for the determination of severity and for the evaluation and prediction of progression, which is suffering from or suspected of suffering from a neurodegenerative disease In a patient's body fluid, the presence and / or concentration of carbamoyl phosphate synthase 1 (CPS 1) is measured, and the conclusion regarding the presence, progression, severity, or treatment success of the neurodegenerative disease is determined. A method derived based on the measured presence and / or concentration, or the inability to detect CPS 1 immunoreactivity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009536327-A |
| priorityDate | 2005-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 220.